138 related articles for article (PubMed ID: 23456648)
1. Quantification of serum HBXAP DNA in lung cancer patients by quantitative fluorescent polymerase chain reaction.
Hou YL; Chen H; Ge MJ; Li FZ; Xue CJ; Wu YF; Luo HX
Mol Biol Rep; 2013 Jun; 40(6):4091-6. PubMed ID: 23456648
[TBL] [Abstract][Full Text] [Related]
2. Quantification of serum SOX2 DNA with FQ-PCR potentially provides a diagnostic biomarker for lung cancer.
Wu Y; Du X; Xue C; Li D; Zheng Q; Li X; Chen H
Med Oncol; 2013 Dec; 30(4):737. PubMed ID: 24126941
[TBL] [Abstract][Full Text] [Related]
3. Quantification of serum MET in non-small-cell lung cancer and its clinical significance.
Li D; Li F; Wu Y; Zhou D; Chen H
Clin Biochem; 2015 Feb; 48(3):110-4. PubMed ID: 25489726
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of serum mitochondrial DNA in lung cancer.
Hou YL; Chen JJ; Wu YF; Xue CJ; Li FZ; Zheng Q; Chen H
Clin Biochem; 2013 Oct; 46(15):1474-7. PubMed ID: 23611926
[TBL] [Abstract][Full Text] [Related]
5. Quantification of plasma hTERT DNA in hepatocellular carcinoma patients by quantitative fluorescent polymerase chain reaction.
Yang YJ; Chen H; Huang P; Li CH; Dong ZH; Hou YL
Clin Invest Med; 2011 Aug; 34(4):E238. PubMed ID: 21810382
[TBL] [Abstract][Full Text] [Related]
6. Quantification of free circulating DNA as a diagnostic marker in lung cancer.
Sozzi G; Conte D; Leon M; Ciricione R; Roz L; Ratcliffe C; Roz E; Cirenei N; Bellomi M; Pelosi G; Pierotti MA; Pastorino U
J Clin Oncol; 2003 Nov; 21(21):3902-8. PubMed ID: 14507943
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus pX interacts with HBXAP, a PHD finger protein to coactivate transcription.
Shamay M; Barak O; Doitsh G; Ben-Dor I; Shaul Y
J Biol Chem; 2002 Mar; 277(12):9982-8. PubMed ID: 11788598
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of a chromatin remodeling factor, RSF-1/HBXAP, correlates with aggressive oral squamous cell carcinoma.
Fang FM; Li CF; Huang HY; Lai MT; Chen CM; Chiu IW; Wang TL; Tsai FJ; Shih IeM; Sheu JJ
Am J Pathol; 2011 May; 178(5):2407-15. PubMed ID: 21514451
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells transduced with Rsf-1/HBXAP gene generate specific cytotoxic T lymphocytes against ovarian cancer in vitro.
Sun L; Kong B; Sheng X; Sheu JJ; Shih IeM
Biochem Biophys Res Commun; 2010 Apr; 394(3):633-8. PubMed ID: 20226169
[TBL] [Abstract][Full Text] [Related]
10. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of plasma DNA for the early detection of lung cancer by quantitative methylation-specific PCR.
Ostrow KL; Hoque MO; Loyo M; Brait M; Greenberg A; Siegfried JM; Grandis JR; Gaither Davis A; Bigbee WL; Rom W; Sidransky D
Clin Cancer Res; 2010 Jul; 16(13):3463-72. PubMed ID: 20592015
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of serum transforming growth factor-β1 in lung cancer.
Hou YL; Chen H; Dong ZH; Xue CJ; Wu YF; Luo HX; Wu YC; Li CH
Cancer Epidemiol; 2013 Oct; 37(5):750-3. PubMed ID: 23727122
[TBL] [Abstract][Full Text] [Related]
13. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
14. Circulating long non-coding RNA AFAP1-AS1 is a potential diagnostic biomarker for non-small cell lung cancer.
Li W; Li N; Kang X; Shi K
Clin Chim Acta; 2017 Dec; 475():152-156. PubMed ID: 29080690
[TBL] [Abstract][Full Text] [Related]
15. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
[TBL] [Abstract][Full Text] [Related]
16. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.
Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C
J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270
[TBL] [Abstract][Full Text] [Related]
17. Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer.
Sirera R; Bremnes RM; Cabrera A; Jantus-Lewintre E; Sanmartín E; Blasco A; Del Pozo N; Rosell R; Guijarro R; Galbis J; Sánchez JJ; Camps C
J Thorac Oncol; 2011 Feb; 6(2):286-90. PubMed ID: 21252717
[TBL] [Abstract][Full Text] [Related]
18. Plasma cell-free DNA level and its integrity as biomarkers to distinguish non-small cell lung cancer from tuberculosis.
Leng S; Zheng J; Jin Y; Zhang H; Zhu Y; Wu J; Xu Y; Zhang P
Clin Chim Acta; 2018 Feb; 477():160-165. PubMed ID: 29113814
[TBL] [Abstract][Full Text] [Related]
19. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma.
Kneip C; Schmidt B; Seegebarth A; Weickmann S; Fleischhacker M; Liebenberg V; Field JK; Dietrich D
J Thorac Oncol; 2011 Oct; 6(10):1632-8. PubMed ID: 21694641
[TBL] [Abstract][Full Text] [Related]
20. Midkine mRNA level in peripheral blood mononuclear cells is a novel biomarker for primary non-small cell lung cancer: a prospective study.
Ma Z; Li H; Wang B; Shen Q; Cui E; Min L; Qian F; Ping J; Dai L
J Cancer Res Clin Oncol; 2013 Apr; 139(4):557-62. PubMed ID: 23224432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
